ZA903749B - Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars - Google Patents

Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars

Info

Publication number
ZA903749B
ZA903749B ZA903749A ZA903749A ZA903749B ZA 903749 B ZA903749 B ZA 903749B ZA 903749 A ZA903749 A ZA 903749A ZA 903749 A ZA903749 A ZA 903749A ZA 903749 B ZA903749 B ZA 903749B
Authority
ZA
South Africa
Prior art keywords
alpha
galactoside
composition
linked
containing sugars
Prior art date
Application number
ZA903749A
Other languages
English (en)
Inventor
Alan E Kligerman
E Kligerman Alan
Original Assignee
Aek Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23385155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA903749(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aek Dev Corp filed Critical Aek Dev Corp
Publication of ZA903749B publication Critical patent/ZA903749B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA903749A 1989-05-16 1990-05-16 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars ZA903749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35244189A 1989-05-16 1989-05-16

Publications (1)

Publication Number Publication Date
ZA903749B true ZA903749B (en) 1991-08-28

Family

ID=23385155

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903749A ZA903749B (en) 1989-05-16 1990-05-16 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars

Country Status (17)

Country Link
US (3) US5989544A (de)
EP (1) EP0472588B2 (de)
JP (1) JPH0725695B2 (de)
KR (1) KR0178029B1 (de)
AT (1) ATE135165T1 (de)
AU (1) AU629941B2 (de)
CA (2) CA2329486C (de)
DE (1) DE69025933T3 (de)
DK (1) DK0472588T4 (de)
ES (1) ES2084696T5 (de)
FI (1) FI915402A0 (de)
GR (1) GR1000903B (de)
IE (1) IE81156B1 (de)
NZ (1) NZ233582A (de)
PE (1) PE2591A1 (de)
WO (1) WO1990014101A1 (de)
ZA (1) ZA903749B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5445957A (en) * 1994-02-10 1995-08-29 Triarco Industries, Inc. Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase
US6099844A (en) * 1994-08-22 2000-08-08 Triarco Industries, Inc. Increasing yield of extractable substances from botanicals with an enzyme composition
AU7210396A (en) * 1995-10-10 1997-04-30 Novo Nordisk A/S Method of improving lipid digestion
DE69815516T2 (de) * 1998-06-24 2004-05-06 Sraum Di Ezio Bartocci & C. S.A.S. Lebensmittel basierend auf Cerealien, insbesondere für die menschliche Ernährung
IL125423A (en) * 1998-07-20 2004-08-31 Israel State Alkaline alpha-galactosidase having broad substrate specificity
US20060198934A1 (en) * 2005-03-01 2006-09-07 Ronald S.O. Zane Process for removing flatulence-associated oligosaccharides in legumes
EP2120892A4 (de) * 2007-02-14 2011-05-18 Neil A Solomon Lactaseformulierung
MX2010012479A (es) * 2010-11-16 2012-05-16 Posi Visionary Solutions Llp Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion.
ITMI20111154A1 (it) * 2011-06-24 2012-12-25 Promefarm Srl Composizioni farmaceutiche o nutrizionali comprendenti galattosidasi e loro uso
US20130084313A1 (en) * 2011-09-30 2013-04-04 Stomavite, Llc Supplement for ostomy patients
US9402885B2 (en) 2013-07-15 2016-08-02 Alfa Wassermann S.P.A. Method of treating GERD with alpha and beta galactosidases
US10808268B2 (en) * 2016-05-24 2020-10-20 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
CA3186646A1 (en) * 2020-07-23 2022-01-27 Anjie Liu Food supplement composition to aid in digestion of fructan, mannitol, and sorbitol

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1008583A (en) * 1961-04-25 1965-10-27 Olin Mathieson Controlled release medicaments
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
US3479122A (en) 1967-04-05 1969-11-18 Takaji Funahashi Writing instrument
US3632346A (en) * 1968-04-30 1972-01-04 Rohm & Haas Process for rendering innocuous flatulence-producing saccharides
JPS4826978A (de) * 1971-08-12 1973-04-09
US3846239A (en) 1972-07-24 1974-11-05 Monsanto Co Process for the preparation of heat-resistant alpha-galactosidase enzyme
US3795585A (en) * 1972-08-31 1974-03-05 Agency Ind Science Techn Method for manufacture of alpha-galactosidase
CH585793A5 (de) * 1974-02-01 1977-03-15 Nestle Sa
GB1446965A (en) * 1974-02-14 1976-08-18 Agricultural Vegetable Prod Preparation of food products
JPS5344556B2 (de) * 1974-03-18 1978-11-29
JPS5322158B2 (de) * 1974-05-02 1978-07-06
US4241185A (en) * 1979-02-23 1980-12-23 The Great Western Sugar Company Method of stabilizing α-galactosidase
IT1130242B (it) * 1980-02-01 1986-06-11 Anic Spa Procedimento per la produzione dell'enzima alfa-galattosidasi e per l'idrolisi del raffinosio mediante l'impiego dell'enzima stesso
US4376127A (en) * 1981-01-23 1983-03-08 Lunde Kenneth E Process for deflatulating and improving the digestibility of legumes
JPS5843075B2 (ja) † 1981-03-03 1983-09-24 株式会社 林原生物化学研究所 α−Ｄ−ガラクトシダ−ゼの製造方法
JPS5843075A (ja) * 1981-09-09 1983-03-12 Canon Inc 印字装置付電子機器
EP0081261B1 (de) 1981-11-30 1986-10-15 Josep Ramisa Navarro Vorrichtung zur Zerstäubung von vernebeltem Wasser
IT1140312B (it) 1981-12-03 1986-09-24 Anic Spa Procedimento per la produzione di alfa-galattosidasi e impieghi dell'enzima cosi' ottenuto
DE176971T1 (de) * 1984-09-29 1986-11-27 Wakamoto Pharmaceutical Co., Ltd., Tokio/Tokyo Fuer ein thermostabiles beta-galaktosidase, kodierendes gen, dieses gen enthaltender bacillus-subtilis, das durch dieses gen kodiertes enzym und verfahren zu dessen herstellung.
DK80588A (da) 1987-02-23 1988-08-24 Suomen Sokeri Oy Fjerkrae-foder, fodringsmetode og fremgangsmaade til forbedring af fordoejeligheden af fjerkrae-foder
FR2611778B1 (fr) * 1987-02-26 1992-04-24 Paris Ouest Entreprise Plancher a collaboration bois-beton
FI78814C (fi) 1987-03-30 1989-10-10 Cultor Oy Nollfiber innehaollande foderraoaemne och foder samt foerfarande foer deras framstaellning.
US5179023A (en) 1989-03-24 1993-01-12 Research Corporation Technologies, Inc. Recombinant α-galactosidase a therapy for Fabry disease
EP0463109A4 (en) * 1989-03-24 1992-11-19 Research Corporation Technologies, Inc. Recombinant alpha-galactosidase, a therapy for fabry disease
FR2647638A1 (fr) 1989-05-30 1990-12-07 Euretec Gie Composition alimentaire contenant un enzyme
US5445957A (en) 1994-02-10 1995-08-29 Triarco Industries, Inc. Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase

Also Published As

Publication number Publication date
FI915402A7 (fi) 1991-11-15
JPH0725695B2 (ja) 1995-03-22
DE69025933D1 (de) 1996-04-18
CA2329486A1 (en) 1990-11-17
IE81156B1 (en) 2000-05-03
GR1000903B (el) 1993-03-16
AU5640690A (en) 1990-12-18
EP0472588A1 (de) 1992-03-04
DK0472588T4 (da) 2002-02-18
ES2084696T5 (es) 2002-08-16
US5989544A (en) 1999-11-23
DK0472588T3 (da) 1996-04-01
CA2055506A1 (en) 1990-11-17
ATE135165T1 (de) 1996-03-15
EP0472588A4 (en) 1992-05-06
KR0178029B1 (ko) 1999-03-20
CA2055506C (en) 2001-02-13
CA2329486C (en) 2004-11-02
ES2084696T3 (es) 1996-05-16
GR900100374A (en) 1991-10-10
PE2591A1 (es) 1991-02-05
DE69025933T3 (de) 2002-09-05
IE901742L (en) 1990-11-16
EP0472588B1 (de) 1996-03-13
WO1990014101A1 (en) 1990-11-29
FI915402A0 (fi) 1991-11-15
EP0472588B2 (de) 2002-01-02
NZ233582A (en) 1992-05-26
AU629941B2 (en) 1992-10-15
US20020106366A1 (en) 2002-08-08
JPH05500043A (ja) 1993-01-14
US6344196B1 (en) 2002-02-05
KR920700680A (ko) 1992-08-10
DE69025933T2 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
ZA903749B (en) Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars
AU653026B2 (en) Physiologically active polypeptide-containing pharmaceutical composition
GR3035093T3 (en) Use of bile salt-activated lipase as dietary supplement.
JPS5771377A (en) Sweetening agent having low cariogenicity
PT1586314E (pt) Composição de comprimidos de nateglinida
GR3015917T3 (en) Enteral diet for patients with pulmonary disease.
AU5269386A (en) Method for the preparation of esters of a non-reducing sugar and one or more fatty acids
ES2097162T3 (es) Utilizacion de acidos grasos de cadena corta en alimentacion clinica.
AU7171887A (en) Pellet for administration to ruminants
ZA861459B (en) Pharmaceutical and dietary compositions
IKEGAMI et al. Effect of indigestible polysaccharides on pancreatic exocrine secretion and biliary output
Yamamoto et al. Effect of carboxymethylcellulose α-starch, and wheat gluten incorporated in diets as binders on growth, feed efficiency, and digestive enzyme activity of fingerling Japanese flounder
GR3004069T3 (de)
SE8505527D0 (sv) Preparat for forbettring av den cellulera metabolismen
SG44838A1 (en) Insulin and amylin containing composition for the treatment of insulin deficient mammals
MD186C2 (ro) Metodă de tratament al endometritei după operaţia cezariană
JPS5738724A (en) Blood sugar level lowering agent
JPS5664743A (en) Method of canning sweetened persimmon
World Health Organization DIARRHOEAL ILLNESS ON A CRUISE SHIP= MALADIE DIARRHÉIQUE SUR UN NAVIRE DE CROISIÈRE
JPS5429158A (en) Thermal insulating electric kettle
Bandurko et al. Enzymes in the mucosal layer of the small intestine
MacDonald et al. Protective action of carbenoxolone on pickle-induced gastric injury in man
AU559938B2 (en) Magnesium or alloy hinged capsule for administration to ruminants
ÇEVİK et al. The relationship between fructosamine and malondialdehyde formation during the inhibition of fructosamine with aspirin
RU95110776A (ru) Композиция для лечения осложнений диабета, применение 6-десатурированной н-6 жирной кислоты для лечения осложнений сахарного диабета, способ получения лекарственного средства, аскорбатный эфир 6-десатурированной н-6 эссенциальной жирной кислоты, его применение